Missing an HRT Dose: What to Do, What to Expect, and When to Call Your Doctor

The Safe First Response

Menopause hormone therapy is a category, not one dosing schedule. It can include an estradiol tablet, a once- or twice-weekly patch, a daily gel or spray, vaginal estrogen, oral progesterone, or a combined estrogen-progestogen product. The correct response to a missed dose therefore begins with the pharmacy label and the current patient instructions for the exact product.

Use this sequence:

1. Confirm which component was missed. Estrogen and endometrial-protective progestogen do not have interchangeable roles.
2. Read the missed-dose or instructions-for-use section supplied with that product.
3. If the instructions are unclear, ask the dispensing pharmacist or prescriber before taking an extra dose.
4. Do not double a dose or compress a cyclic progesterone schedule based on a generic internet rule.

A Missed Patch Does Not Automatically Reset the Calendar

The current Vivelle-Dot instructions are unusually specific. If a scheduled patch change is forgotten, the patient should apply a new patch as soon as it is remembered and still follow the original marked twice-weekly schedule. If a patch falls off, it may be reapplied; if it cannot be reapplied, a new patch goes on another approved area while the original schedule remains in place [1].

That directly contradicts the common advice to reset every future change day after a late patch. Other patch brands can have different schedules and instructions, so the product name matters.

The same label says an interruption may increase the likelihood of breakthrough bleeding, spotting, or recurrence of symptoms [1]. It does not establish a universal number of hours after which symptoms will return, and it does not support using serum estradiol half-life as a personalized catch-up clock.

Oral Estrogen, Gels, and Sprays Need Their Own Instructions

Formulation-specific pharmacokinetics do not create a universal missed-dose rule. Even products containing estradiol can differ in strength, delivery system, dosing frequency, and patient instructions. A rule such as "take it unless the next dose is within four hours" should not be applied to every oral estrogen unless that exact product's labeling says so.

The practical distinction is:

• a late dose is an adherence question governed by the product instructions;
• repeated missed doses are a treatment-plan question for the prescriber; and
• severe or new symptoms are a clinical assessment question, not a dosing-arithmetic problem.

Why a Missed Progestogen Deserves Special Attention

For a patient with a uterus who uses systemic estrogen, the prescribed progestogen schedule may be intended to reduce the risk of endometrial hyperplasia. The current Prometrium label, for example, describes a specific cyclic regimen when it is used with daily conjugated estrogen [2]. That does not mean every patient uses the same progesterone product or schedule.

If a progesterone dose is missed:

• do not substitute an estrogen-only catch-up plan;
• do not take two capsules together unless the product instructions or clinician directs it;
• check whether the regimen is continuous or cyclic; and
• call the pharmacist or prescriber if more than one dose was missed, the schedule is unclear, or unexpected bleeding develops.

Persistent or unexplained vaginal bleeding should be evaluated. The Prometrium patient information specifically tells patients to seek care for unusual vaginal bleeding [2].

What You May Notice After an Interruption

The most defensible expected effects are the ones stated in product labeling: spotting or bleeding and recurrence of the symptoms the therapy was controlling [1]. Whether that happens after one late dose varies by product, regimen, and patient.

There is no good basis for promising that:

• oral symptoms will return within exactly 24 hours;
• a patch creates a fixed 24- to 36-hour buffer for everyone;
• spotting will resolve within a fixed number of days; or
• a blood estradiol result can tell a patient how to replace a missed dose.

If missed doses are frequent, address the adherence problem directly. A reminder system, a visible patch-change calendar, or discussion of a formulation with a more workable schedule may be more useful than repeated catch-up instructions.

One Missed Dose Is Not the Same as Stopping Hormone Therapy

Stopping a long-term regimen is a separate decision. In the Women's Health Initiative discontinuation survey, vasomotor symptoms were more common after active estrogen-plus-progestin therapy ended, especially among women who had symptoms before treatment [3]. That study does not show that one missed dose causes a predictable withdrawal syndrome.

Evidence also does not establish one superior discontinuation method. In a randomized trial, tapering combined therapy did not reduce hot-flash recurrence or resumption of therapy compared with abrupt discontinuation over 12 months [4]. A prescriber may still individualize a taper to make symptom management easier, but a universal three- or six-month taper should not be presented as proven.

How Long Can Menopause Hormone Therapy Continue?

The 2022 Menopause Society position statement says treatment should be individualized with periodic reevaluation. It reports a generally favorable benefit-risk ratio for many symptomatic patients younger than 60 or within 10 years of menopause onset when no contraindication is present. For longer treatment, the indication, formulation, route, and changing risk profile matter [5].

That is not a blanket promise that therapy has no duration limit, and it is not a reason to stop because of one missed dose. The decision should be revisited periodically with the clinician who knows the indication and risk factors.

HRT Is Not Contraception

Menopause hormone therapy should not be assumed to suppress ovulation or prevent pregnancy. Patients who may still be fertile need a separate contraception plan appropriate to their age and medical history. Guidance for contraception later in reproductive life is distinct from guidance for menopause symptom treatment [6].

If pregnancy is possible after missed hormones or missed contraception, use the instructions for the contraceptive method and contact a clinician or pharmacist promptly. Do not treat a menopause-hormone dose as emergency contraception.

When to Call and When to Seek Urgent Care

Contact the prescriber or pharmacist when:

• the product instructions do not explain what to do;
• more than one estrogen or progestogen dose was missed;
• a cyclic progesterone schedule has been disrupted;
• bleeding is new, persistent, heavy, or otherwise concerning; or
• symptoms repeatedly return because adherence is difficult.

Seek urgent assessment for chest pain, sudden shortness of breath, one-sided leg swelling or pain, sudden severe headache, weakness or numbness, difficulty speaking, or sudden visual loss. These symptoms require evaluation regardless of whether a dose was missed.

References

1. DailyMed. Vivelle-Dot (estradiol transdermal system), patient information and instructions for use. Revised November 2023. Vivelle-Dot official label
2. DailyMed. Prometrium (progesterone) capsules, prescribing and patient information. Updated January 2026. Prometrium official label
3. Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA. 2005;294(2):183-193. Symptom experience after discontinuing use of estrogen plus progestin
4. Lindh-Astrand L, Bixo M, Hirschberg AL, Sundstrom-Poromaa I, Hammar M. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms. Menopause. 2010;17(1):72-79. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms
5. The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. The 2022 hormone therapy position statement of The North American Menopause Society
6. Faculty of Sexual and Reproductive Healthcare. Contraception for Women Aged Over 40 Years. Amended July 2023, updated May 2025. FSRH contraception guideline